- Sample required: 3 vials with 3 mL of saliva
- Lab reporting time: 3 - 5
- business days
Overview
This profile measures estradiol, progesterone and testosterone
on each of three days and DHEA-S on one of the days. It can
be used to establish baseline levels of sex hormones and also
to monitor the efficacy of adjunctive hormone therapies.
Physiology
Estradiol and progesterone are “female” hormones
that among other things regulate the menstrual cycle in pre-menopausal
women. When a woman’s adrenal function is compromised
as a result of chronic stress, an outcome can be a reduction
in sex hormones, with progesterone affected to a greater extent
than the estrogens. (Refer to Functional Adrenal Stress Profile
plus V (BHD # 205).) Prior to menopause up to 30% of female
hormones are produced in the adrenals, after menopause up
to 50% are produced in the adrenals.
Testosterone is a “male” hormone which also in
women maintains lean body mass, bone density, skin elasticity
and libido. DHEA modulates many physiological processes, including
the immune function in addition to being a precursor from
which testosterone and the estrogens are formed.
Clinical Use
The 3-Day Female Sex Hormone Profile (BHD #235) is used to
assess sex hormone levels. This profile can be used both to
establish baseline levels of sex hormones and also to monitor
the efficacy of adjunctive hormone therapies.
Conditions Assessed
This profile assesses sex hormone imbalance. Examples include
conditions resulting from inappropriate hormone replacement
therapy, high or low libido, dysmenorrhea, premature menopause,
feminization, and masculinization.
Logical Sequence of Testing
The logical sequence of using this test as an initial or as
a follow-up test is determined by a variety of individual
considerations, including the patient’s chief complaint,
the array of signs and symptoms, the chronicity of the condition,
the tests previously taken, and the judgment of the practitioner.
Technical assistance is available from BioHealth Diagnostics’
support staff.
|